No trading action required. This is a standard annual meeting with routine governance votes that do not signal any strategic changes or financial developments.
PRTA drugs
PRTA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 30 $9.25entry
- T+1 · 8mo ago +5.08%α +2.19% · $9.72
- T+5 · 7mo ago +12.00%α +7.70% · $10.36
- T+20 · 7mo ago +24.43%α +11.84% · $11.51
- T+60 · 5mo ago +0.22%α −16.28% · $9.27
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Prothena Corp PLC is holding its 2026 Annual General Meeting to elect two directors and vote on non-binding resolutions regarding auditor appointment and executive compensation. This is a routine annual shareholder meeting with no material financial impact.
Key Financial Metrics
Key Facts
- Two director nominees: Shane M. Cooke and Dennis J. Selkoe
- Vote to ratify KPMG LLP as independent auditor for fiscal year 2026
- Non-binding advisory vote on executive compensation
- Meeting date: May 14, 2026 at The Merrion Hotel in Dublin, Ireland
Financial Impact
None - routine governance matters
Risk Factors
- None identified - standard proxy filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-011737 |
| Document: 0001140361-26-011737-index-headers.html | 0001140361-26-011737 |
| Document: 0001140361-26-011737-index.html | 0001140361-26-011737 |
| Document: 0001140361-26-011737.txt | 0001140361-26-011737 |
Track record
20 reports on PRTA
8 of 12 bullish or bearish reports moved the stock their way by T+1. Best: +14.11% at T+60 after the Jun 12, 2026 report. 9 of 12 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
- Nov 10, 20266d ago Insider Buy Bullish 5/10 Entry $8.56 to $8.73 Now $7.97 −6.89% ▲ +1.99% +0.67% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $7.97 to $8.78 Now $7.97 −0.00% ▲ +10.10% +7.73% vs SPY
- Oct 29, 202618d ago 8-K Bearish 6/10 Entry $8.47 to $8.29 Now $7.97 +5.90% ▲ +2.13% +1.65% vs SPY
- Oct 26, 202621d ago Insider Buy Bullish 5/10 Entry $8.81 to $9.10 Now $7.97 −9.53% ▲ +3.29% +2.95% vs SPY
- Oct 15, 20264w ago Insider Buy Bullish 5/10 Entry $8.35 to $8.48 Now $7.97 −4.55% ▲ +1.56% +1.13% vs SPY
- Sep 30, 20266w ago Insider Buy Bullish 5/10 Entry $8.54 to $8.36 Now $7.97 −6.67% ▼ −2.11% −2.85% vs SPY
- Sep 29, 20266w ago Insider Buy Bullish 5/10 Entry $8.38 to $8.54 Now $7.97 −4.89% ▲ +1.91% +1.73% vs SPY
- Sep 21, 20268w ago Insider Buy Bullish 6/10 Entry $8.99 to $8.68 Now $7.97 −11.35% ▼ −3.45% −2.73% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers